ADMA Biologics (ADMA) Revenue & Revenue Breakdown
ADMA Biologics Revenue Highlights
Latest Revenue (Y)
$258.21M
Latest Revenue (Q)
$119.84M
Main Segment (Y)
ADMA BioManufacturing Segment
Main Geography (Y)
United States
ADMA Biologics Revenue by Period
ADMA Biologics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $258.21M | 67.59% |
2022-12-31 | $154.08M | 90.36% |
2021-12-31 | $80.94M | 91.72% |
2020-12-31 | $42.22M | 43.85% |
2019-12-31 | $29.35M | 72.79% |
2018-12-31 | $16.99M | -25.37% |
2017-12-31 | $22.76M | 113.49% |
2016-12-31 | $10.66M | 48.53% |
2015-12-31 | $7.18M | 21.34% |
2014-12-31 | $5.92M | 92.84% |
2013-12-31 | $3.07M | 174.35% |
2012-12-31 | $1.12M | 100.00% |
2011-06-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2007-06-30 | - | - |
ADMA Biologics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $119.84M | 11.80% |
2024-06-30 | $107.19M | 30.92% |
2024-03-31 | $81.88M | 10.79% |
2023-12-31 | $73.90M | 9.85% |
2023-09-30 | $67.27M | 11.89% |
2023-06-30 | $60.12M | 5.64% |
2023-03-31 | $56.91M | 13.87% |
2022-12-31 | $49.98M | 21.64% |
2022-09-30 | $41.09M | 21.19% |
2022-06-30 | $33.91M | 16.50% |
2022-03-31 | $29.10M | 10.31% |
2021-12-31 | $26.38M | 27.57% |
2021-09-30 | $20.68M | 15.98% |
2021-06-30 | $17.83M | 11.10% |
2021-03-31 | $16.05M | 14.99% |
2020-12-31 | $13.96M | 35.81% |
2020-09-30 | $10.28M | 31.96% |
2020-06-30 | $7.79M | -23.65% |
2020-03-31 | $10.20M | -15.26% |
2019-12-31 | $12.04M | 66.66% |
2019-09-30 | $7.22M | 10.08% |
2019-06-30 | $6.56M | 85.94% |
2019-03-31 | $3.53M | -13.01% |
2018-12-31 | $4.06M | -4.11% |
2018-09-30 | $4.23M | -9.15% |
2018-06-30 | $4.66M | 15.20% |
2018-03-31 | $4.04M | -66.32% |
2017-12-31 | $12.00M | 153.79% |
2017-09-30 | $4.73M | 39.12% |
2017-06-30 | $3.40M | 29.31% |
2017-03-31 | $2.63M | -21.00% |
2016-12-31 | $3.33M | 13.26% |
2016-09-30 | $2.94M | 29.32% |
2016-06-30 | $2.27M | 6.96% |
2016-03-31 | $2.12M | -15.46% |
2015-12-31 | $2.51M | 35.62% |
2015-09-30 | $1.85M | 41.41% |
2015-06-30 | $1.31M | -12.85% |
2015-03-31 | $1.50M | 0.97% |
2014-12-31 | $1.49M | 8.99% |
2014-09-30 | $1.37M | -8.96% |
2014-06-30 | $1.50M | -3.86% |
2014-03-31 | $1.56M | 268.03% |
2013-12-31 | $424.03K | -61.71% |
2013-09-30 | $1.11M | 48.98% |
2013-06-30 | $743.27K | -6.26% |
2013-03-31 | $792.93K | 51.53% |
2012-12-31 | $523.28K | 45.22% |
2012-09-30 | $360.34K | 56.60% |
2012-06-30 | $230.10K | 5129.45% |
2012-03-31 | $4.40K | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | 100.00% |
2007-09-30 | - | - |
ADMA Biologics Revenue Breakdown
ADMA Biologics Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 19 |
---|---|---|---|---|
Plasma Collection Centers Segment | $8.12M | - | - | - |
ADMA BioManufacturing Segment | $161.16M | - | - | - |
Product Revenue | - | $153.94M | $80.80M | - |
License Revenue | - | $142.83K | $142.83K | - |
Corporate | - | - | - | $142.83K |
ADMA BioManufacturing | - | - | - | $22.18M |
Plasma Collection Centers | - | - | - | $7.03M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA BioManufacturing Segment | $113.09M | $80.11M | $51.82M | $59.76M | $49.58M | - | - | - | - | - | - | - | - | - | - | - | - |
Plasma Collection Centers Segment | $7.45M | $1.78M | $488.76K | $326.35K | $7.30M | - | - | - | - | - | - | - | - | - | - | - | - |
Corporate Segment | $36.00K | $36.00K | $35.71K | $35.71K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Product Revenue | - | - | - | - | - | $49.95M | $41.05M | $33.87M | $29.07M | $26.35M | $20.64M | $17.79M | - | - | - | - | - |
License Revenue | - | - | - | - | - | $35.71K | $35.71K | $35.71K | $35.71K | $35.71K | $35.71K | $35.71K | - | - | - | - | - |
ADMA BioManufacturing | - | - | - | - | - | - | - | - | - | - | - | - | $7.74M | $10.96M | $5.87M | $4.00M | $1.34M |
Plasma Collection Centers | - | - | - | - | - | - | - | - | - | - | - | - | $2.42M | $1.04M | $1.32M | $2.52M | $2.15M |
Corporate | - | - | - | - | - | - | - | - | - | - | - | - | $35.71K | $35.71K | $35.71K | $35.71K | $35.71K |
Latest
ADMA Biologics Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 22 |
---|---|
United States | $146.43M |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Mar 24 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
---|---|---|---|---|---|---|---|---|
United States | $114.75M | $77.99M | $56.61M | $52.69M | $49.98M | $37.85M | $31.27M | $27.32M |
International | $5.09M | $3.88M | - | - | - | - | - | - |
Latest
ADMA Biologics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BCRX | BioCryst Pharmaceuticals | $331.41M | $117.08M |
ADMA | ADMA Biologics | $258.21M | $119.84M |
AKBA | Akebia Therapeutics | $194.62M | $35.59M |
MCRB | Seres Therapeutics | $126.33M | - |
RCUS | Arcus Biosciences | $117.00M | $48.00M |
ACLX | Arcellx | $110.32M | $26.03M |
CDTX | Cidara Therapeutics | $63.91M | - |
FATE | Fate Therapeutics | $63.53M | $6.77M |
CRBU | Caribou Biosciences | $34.48M | $3.46M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
ATRA | Atara Biotherapeutics | $8.57M | $40.19M |
TNXP | Tonix Pharmaceuticals | $7.77M | $2.21M |
VXRT | Vaxart | $7.38M | $6.40M |
PLRX | Pliant Therapeutics | $1.58M | - |
TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
ANEB | Anebulo Pharmaceuticals | - | - |
XFOR | X4 Pharmaceuticals | - | $563.00K |
ANTX | AN2 Therapeutics | - | - |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
ETNB | 89bio | - | - |
SANA | Sana Bio | - | - |
INMB | INmune Bio | $-155.00K | - |